Clinical Trial Update: Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of theophylline to treat chronic lymphocytic leukemia in situ, stage I, or stage II.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED